Our study suggested that MYC could bind to the promoter region of MTHFD2 and transcriptionally regulate MTHFD2 in NSCLC, consistent with previous experiments in acute myeloid leukemia [12] and colorectal cancer [26]. This evidence concerns the gene MYC and non-small cell lung carcinoma.